Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrilin plus stenting to avoid myocardial necrosis trial pilot study
2006-003684-32Phase 4Active
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Oct 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis comparing Eptifibatide pre-procedural arm with Placebo pre-procedural arm (2 arms). Primary endpoint: Post-procedural peak CK-MB ratio above upper limit of normal. Started Oct 2006; status: active.
02
Drugs
eptifibatide
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-003684-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003684-32.